284 related articles for article (PubMed ID: 10825037)
41. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
[TBL] [Abstract][Full Text] [Related]
42. Use of protein C concentrate in pediatric patients with sepsis.
Silvani P; Camporesi A; Licari E; Wolfler A
Minerva Anestesiol; 2005 Jun; 71(6):373-8. PubMed ID: 15886604
[TBL] [Abstract][Full Text] [Related]
43. A role for dopexamine hydrochloride in septic shock.
Murphy R
Ir Med J; 1998; 91(5):180. PubMed ID: 9973758
[No Abstract] [Full Text] [Related]
44. Administration of antibiotics before admission in patients with meningococcal disease.
Roznovský L; Krízová P; Struncová V; Dostál V; Plísek S; Kasal E; Burget I; Chalupa P; Dlouhý P
Cent Eur J Public Health; 2003 Mar; 11(1):14-8. PubMed ID: 12690797
[TBL] [Abstract][Full Text] [Related]
45. Single nucleotide polymorphisms in genes of circulatory homeostasis in surviving pediatric intensive care patients with meningococcal infection.
Bunker-Wiersma HE; Koopmans RP; Kuipers TW; Knoester H; Bos AP
Pediatr Crit Care Med; 2008 Sep; 9(5):517-23. PubMed ID: 18679149
[TBL] [Abstract][Full Text] [Related]
46. Target attainment of cefotaxime in critically ill children with meningococcal septic shock as a model for cefotaxime dosing in severe pediatric sepsis.
Hartman SJF; Boeddha NP; Ekinci E; Koch BCP; Donders R; Hazelzet JA; Driessen GJ; de Wildt SN
Eur J Clin Microbiol Infect Dis; 2019 Jul; 38(7):1255-1260. PubMed ID: 30968258
[TBL] [Abstract][Full Text] [Related]
47. Effectiveness of a human monoclonal anti-endotoxin antibody (HA-1A) in gram-negative sepsis: relationship to endotoxin and cytokine levels.
Wortel CH; von der Möhlen MA; van Deventer SJ; Sprung CL; Jastremski M; Lubbers MJ; Smith CR; Allen IE; ten Cate JW
J Infect Dis; 1992 Dec; 166(6):1367-74. PubMed ID: 1431255
[TBL] [Abstract][Full Text] [Related]
48. Serum level of cardiac troponin I in pediatric patients with sepsis or septic shock.
Oliveira NS; Silva VR; Castelo JS; Elias-Neto J; Pereira FE; Carvalho WB
Pediatr Crit Care Med; 2008 Jul; 9(4):414-7. PubMed ID: 18843251
[TBL] [Abstract][Full Text] [Related]
49. [Immunotherapy using the anti-endotoxin antibody HA-1A (Centoxin) in patients with sepsis syndrome; fair results following protocol selection of patients].
Costongs LG; Speelman P; van Lieshout JJ; van Deventer SJ; Lubbers MJ; Schipper HG
Ned Tijdschr Geneeskd; 1993 Feb; 137(7):355-60. PubMed ID: 8437634
[TBL] [Abstract][Full Text] [Related]
50. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial.
Darenberg J; Ihendyane N; Sjölin J; Aufwerber E; Haidl S; Follin P; Andersson J; Norrby-Teglund A;
Clin Infect Dis; 2003 Aug; 37(3):333-40. PubMed ID: 12884156
[TBL] [Abstract][Full Text] [Related]
51. Low-dose hydrocortisone in pediatric septic shock: an exploratory study in a third world setting.
Valoor HT; Singhi S; Jayashree M
Pediatr Crit Care Med; 2009 Jan; 10(1):121-5. PubMed ID: 19057445
[TBL] [Abstract][Full Text] [Related]
52. [Isoproterenol in the treatment of fulminating meningococcemia in children complicated by shock. An analysis of 181 cases].
Liu YL
Zhonghua Yi Xue Za Zhi; 1974; (12):766-70, 214. PubMed ID: 4217259
[No Abstract] [Full Text] [Related]
53. HA-1A. A human monoclonal antibody for the treatment of gram-negative sepsis.
Smith CR; Straube RC; Ziegler EJ
Infect Dis Clin North Am; 1992 Mar; 6(1):253-66. PubMed ID: 1578120
[TBL] [Abstract][Full Text] [Related]
54. Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge.
Buysse CM; Raat H; Hazelzet JA; Hop WC; Maliepaard M; Joosten KF
Crit Care Med; 2008 Feb; 36(2):596-602. PubMed ID: 18216608
[TBL] [Abstract][Full Text] [Related]
55. Endotoxin-binding and -neutralizing properties of recombinant bactericidal/permeability-increasing protein and monoclonal antibodies HA-1A and E5.
Marra MN; Thornton MB; Snable JL; Wilde CG; Scott RW
Crit Care Med; 1994 Apr; 22(4):559-65. PubMed ID: 8143464
[TBL] [Abstract][Full Text] [Related]
56. Endotoxin release and cytokine production in acute and chronic meningococcaemia.
Prins JM; Lauw FN; Derkx BH; Speelman P; Kuijper EJ; Dankert J; van Deventer SJ
Clin Exp Immunol; 1998 Nov; 114(2):215-9. PubMed ID: 9822279
[TBL] [Abstract][Full Text] [Related]
57. Introduction of new technology into critical care practice: a history of HA-1A human monoclonal antibody against endotoxin.
Luce JM
Crit Care Med; 1993 Aug; 21(8):1233-41. PubMed ID: 8339592
[TBL] [Abstract][Full Text] [Related]
58. Human monoclonal antibody against endotoxin.
Zarowitz BJ
DICP; 1991; 25(7-8):778-83. PubMed ID: 1949939
[TBL] [Abstract][Full Text] [Related]
59. Antipyretic efficacy and tolerability of a single intravenous dose of the acetaminophen prodrug propacetamol in children: a randomized, double-blind, placebo-controlled trial.
Walson PD; Jones J; Chesney R; Rodarte A
Clin Ther; 2006 May; 28(5):762-9. PubMed ID: 16861098
[TBL] [Abstract][Full Text] [Related]
60. Corticosteroid therapy in genotype ST-11 meningococcal infections.
Madhi F; Levy C; Deghmane AE; Béchet S; Cohen R; Taha MK; ;
Pediatr Infect Dis J; 2013 Mar; 32(3):291-3. PubMed ID: 23114370
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
